Skip to content
Tirzepatide Report
Provider review

Silhouette MD Tirzepatide Review: Availability and Price

Published by Tirzepatide ReportUpdated

On this page

Current tirzepatide offer and treatment terms unconfirmed.

Things to consider

  • Current product menu and treatment contract could not be reverified
  • Older price, concierge-support and OpenLoop descriptions are not confirmed current offers

We could not confirm a current Silhouette MD tirzepatide offer, price or treatment contract. Earlier listed prices and partner descriptions should not be treated as a current quote. Obtain an active product offer and the full agreement before making a payment.3

On October 29, the homepage displayed a default-server page in a normal browser, with no provider menu or treatment agreement. A separate public request received access denied. Neither response establishes business closure or patient-account status; the server’s generic propagation message is not a confirmed reopening date.4

The earlier price is not a current quote

Our previous listing described $299/month tirzepatide, other oral and injectable options, concierge-style support and an OpenLoop relationship. Those details were not re-established in the current check. We have withdrawn them as confirmed current program facts rather than carrying them forward as an available offer.

Current offer • Confirmation needed

Item to confirmCurrent evidence
Tirzepatide priceCurrent quote unconfirmed
Preparation and supplied quantityCurrent offer unconfirmed
Care and dispensing partnersCurrent arrangement unconfirmed
Renewal and refundsCurrent treatment agreement unconfirmed
Current offer limitations; the earlier $299/month figure is not a verified available rate. No closure or patient-care conclusion is implied.

What to obtain before paying

Ask for the exact named product and preparation, prescribed amount, quantity supplied, total charge and payment period. If a quote is described as monthly, confirm whether that means a separate monthly bill, a four-week supply or an average requiring a larger upfront purchase.

The contract should explain automatic renewal, cancellation notice, unused-plan refunds and what happens if a clinician does not approve medication. We have not verified those conditions for a current Silhouette MD offer. Do not infer a refund guarantee or an unrestricted right to cancel from an older description.

Confirm who provides the care and medication

An earlier mention of OpenLoop is not proof of a current partnership, an assigned clinician or the pharmacy dispensing a particular prescription. Confirm the actual clinical practice, eligibility where you are physically located, the dispensing pharmacy and who handles billing and medication questions.

Likewise, earlier concierge-support language does not confirm current appointment availability, response times or included check-ins. Request the services and any additional charges in writing.

For another published program's care and contract details, our Rebody Health review and provider comparison provide comparison points. Compare accepted quotes and equivalent supplied periods; we are not establishing a current Silhouette MD price difference.

Keep medication evidence separate

Our earlier listing described compounded tirzepatide. That history does not verify a currently dispensed formulation or establish a current brand-name alternative. Compounded tirzepatide is not an FDA-approved finished drug; a particular provider's preparation is not verified by the trials of specified study products and protocols.1,2

Our tirzepatide evidence guide and compounding legal-status guide explain the distinction. Discuss Zepbound side effects, gallbladder risk and the thyroid warning with a licensed prescriber. A clinical decision and an accountable dispensing arrangement matter more than an old provider listing.

Frequently asked questions

Is Silhouette MD tirzepatide currently $299 per month?

We could not reverify a current quote. The older $299/month figure should not be treated as an available price; confirm the accepted product, total charge and supplied period.

Does Silhouette MD still use OpenLoop?

A current partnership, assigned clinician and dispensing pharmacy were not established in this check. The earlier listing is not proof of the current arrangement.

Does this mean Silhouette MD has closed?

No. An inability to verify the current public offer does not establish business closure, the status of existing patient care or what every visitor sees.

References(4)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. Silhouette MD (2026). Recorded public program website; current product offer and treatment terms could not be reverified.. Silhouette MD.
  4. Silhouette MD (2026). Retained official website access rechecked October 29, 2026. Silhouette MD.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Continue reading

Browse provider reviews